149 related articles for article (PubMed ID: 25880149)
1. Disease-modifying therapy and hospitalization risk in heart failure patients.
Shaya FT; Breunig IM; Mehra MR
Am J Manag Care; 2015 Jan; 21(1):39-47. PubMed ID: 25880149
[TBL] [Abstract][Full Text] [Related]
2. First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
Tuppin P; Cuerq A; de Peretti C; Fagot-Campagna A; Danchin N; Juillière Y; Alla F; Allemand H; Bauters C; Drici MD; Hagège A; Jondeau G; Jourdain P; Leizorovicz A; Paccaud F
Arch Cardiovasc Dis; 2013 Nov; 106(11):570-85. PubMed ID: 24140417
[TBL] [Abstract][Full Text] [Related]
3. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
[TBL] [Abstract][Full Text] [Related]
4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
5. A review of heart failure management in the elderly population.
Cheng JW; Nayar M
Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
[TBL] [Abstract][Full Text] [Related]
6. Understanding the economic burden of heart failure in China: impact on disease management and resource utilization.
Huang J; Yin H; Zhang M; Ni Q; Xuan J
J Med Econ; 2017 May; 20(5):549-553. PubMed ID: 28286996
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
8. Prescription in patients with chronic heart failure and multimorbidity attended in primary care.
Frigola-Capell E; Verdú-Rotellar JM; Comin-Colet J; Davins-Miralles J; Hermosilla E; Wensing M; Suñol R
Qual Prim Care; 2013; 21(4):211-9. PubMed ID: 24041138
[TBL] [Abstract][Full Text] [Related]
9. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
10. Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
[TBL] [Abstract][Full Text] [Related]
11. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
12. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
[TBL] [Abstract][Full Text] [Related]
13. [Heart failure in Apulia Region - Italy (Local Health Unit Barletta-Andria-Trani): analysis of the therapeutic pathways, healthcare resource consumption and related costs.].
Perrone V; Sangiorgi D; Degli Esposti L; Modugno G; Dambrosio G; Diaferia G; Delvecchio B; Dell'Orco ML; Masullo M; Ancona D; Deluca G; Campanile V; Narracci O; Nica M; Colombo D; Buda S
Recenti Prog Med; 2019 Jan; 110(1):23-32. PubMed ID: 30720014
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ
J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914
[TBL] [Abstract][Full Text] [Related]
15. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
16. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
17. Health care and medication costs and use among older adults with heart failure.
Stroupe KT; Teal EY; Weiner M; Gradus-Pizlo I; Brater DC; Murray MD
Am J Med; 2004 Apr; 116(7):443-50. PubMed ID: 15047033
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
